[go: up one dir, main page]

AR011437A1 - Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento. - Google Patents

Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.

Info

Publication number
AR011437A1
AR011437A1 ARP980100558A ARP980100558A AR011437A1 AR 011437 A1 AR011437 A1 AR 011437A1 AR P980100558 A ARP980100558 A AR P980100558A AR P980100558 A ARP980100558 A AR P980100558A AR 011437 A1 AR011437 A1 AR 011437A1
Authority
AR
Argentina
Prior art keywords
preparation
treatment
pharmaceutical composition
migranes
same
Prior art date
Application number
ARP980100558A
Other languages
English (en)
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of AR011437A1 publication Critical patent/AR011437A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composicion farmacéutica para el tratamiento de la migrana que contiene una cantidad terapéuticamente efectiva de ibuprofen o su sal farmacéuticamenteaceptable y una cantidad terapéuticamente efectiva de domperidona o su sal farmacéuticamente aceptable junto con un diluyente o portador farmacéuticamenteaceptable y el uso de la misma para la preparacion de un medicamento.
ARP980100558A 1997-02-06 1998-02-09 Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento. AR011437A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9702392.3A GB9702392D0 (en) 1997-02-06 1997-02-06 Therapeutic agents

Publications (1)

Publication Number Publication Date
AR011437A1 true AR011437A1 (es) 2000-08-16

Family

ID=10807167

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980100558A AR011437A1 (es) 1997-02-06 1998-02-09 Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.

Country Status (25)

Country Link
EP (1) EP1017388B1 (es)
JP (1) JP2001511168A (es)
KR (1) KR20000070823A (es)
CN (1) CN1115150C (es)
AR (1) AR011437A1 (es)
AT (1) ATE247466T1 (es)
AU (1) AU724526B2 (es)
BG (1) BG64371B1 (es)
CA (1) CA2279184C (es)
CZ (1) CZ295374B6 (es)
DE (1) DE69817379T2 (es)
DK (1) DK1017388T3 (es)
ES (1) ES2205452T3 (es)
GB (2) GB9702392D0 (es)
HU (1) HU225043B1 (es)
ID (1) ID22416A (es)
IL (1) IL131230A0 (es)
NO (1) NO993784L (es)
PL (1) PL190733B1 (es)
PT (1) PT1017388E (es)
RU (1) RU2195935C2 (es)
SK (1) SK284728B6 (es)
TR (1) TR199901782T2 (es)
WO (1) WO1998034612A1 (es)
ZA (1) ZA98968B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9816899D0 (en) 1998-08-05 1998-09-30 Boots Co Plc Therapeutic agents
GB9822333D0 (en) * 1998-10-13 1998-12-09 Merck Sharp & Dohme Pharmaceutical formulation
HU227045B1 (en) * 1999-12-09 2010-05-28 Reckitt Benckiser Healthcare Compressed tablet composition comprising a nsaid
GB0229258D0 (en) * 2002-12-16 2003-01-22 Boots Healthcare Int Ltd Medicinal compositions
CN101068532B (zh) * 2004-09-30 2012-03-14 斯科尔医药公司 布洛芬改进释放剂型
US20070077297A1 (en) 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US20060068009A1 (en) * 2004-09-30 2006-03-30 Scolr Pharma, Inc. Modified release ibuprofen dosage form
DE102005013726A1 (de) * 2005-03-22 2006-09-28 Grünenthal GmbH Transdermale therapeutische Systeme mit verbesserter Verträglichkeit
US7749537B2 (en) 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
EP2142176A1 (en) * 2007-04-26 2010-01-13 Craig A. Aronchick Compositions and methods for transmucosal delivery of domperidone
CN107773560A (zh) * 2016-08-25 2018-03-09 厦门恩成制药有限公司 一种具有止痛和消炎作用的药用组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2020018A1 (en) * 1990-06-27 1991-12-28 Don L. Simmons Method and composition for treating the migraine complex
GB2313309B (en) * 1996-05-24 2000-01-26 Ninh Thuy On Pharmaceutical compositions comprising a nonsteroidal anti-inflammatory drug and domperidone in the treatment of migraine

Also Published As

Publication number Publication date
GB2331926B (en) 2000-07-12
CN1246795A (zh) 2000-03-08
DE69817379T2 (de) 2004-06-09
TR199901782T2 (xx) 1999-09-21
DK1017388T3 (da) 2003-10-13
NO993784L (no) 1999-09-22
PT1017388E (pt) 2003-12-31
PL190733B1 (pl) 2005-12-30
GB9702392D0 (en) 1997-03-26
ATE247466T1 (de) 2003-09-15
ID22416A (id) 1999-10-14
CN1115150C (zh) 2003-07-23
RU2195935C2 (ru) 2003-01-10
GB9904285D0 (en) 1999-04-21
WO1998034612A1 (en) 1998-08-13
CZ295374B6 (cs) 2005-07-13
SK284728B6 (sk) 2005-10-06
AU6295598A (en) 1998-08-26
SK106299A3 (en) 2000-08-14
BG64371B1 (bg) 2004-12-30
HUP0001104A3 (en) 2000-09-28
IL131230A0 (en) 2001-01-28
NO993784D0 (no) 1999-08-05
PL335089A1 (en) 2000-04-10
CA2279184A1 (en) 1998-08-13
HU225043B1 (en) 2006-05-29
ZA98968B (en) 1998-08-06
JP2001511168A (ja) 2001-08-07
EP1017388B1 (en) 2003-08-20
CA2279184C (en) 2009-04-21
ES2205452T3 (es) 2004-05-01
GB2331926A (en) 1999-06-09
BG103632A (en) 2000-03-31
EP1017388A1 (en) 2000-07-12
KR20000070823A (ko) 2000-11-25
AU724526B2 (en) 2000-09-21
CZ270999A3 (cs) 1999-10-13
DE69817379D1 (de) 2003-09-25
HUP0001104A2 (hu) 2000-08-28

Similar Documents

Publication Publication Date Title
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
AR012376A1 (es) Formulacion de gel para la aplicacion topica
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
AR064895A2 (es) Composicion farmaceutica anhidra para el tratamiento de desordenes inducidos por histamina
FI954767A (fi) Lipofiilisiä lääkeaineita sisältävä farmaseuttinen koostumus
AR028299A1 (es) Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes.
BR9607862A (pt) Composição farmacêutica filmogênica para administração transdérmica
CL2004001191A1 (es) Compuestos derivados de esteroides 17 alpha-fluoroalquilados, con actividad antigestagena; composicion farmaceutica; combinacion farmaceutica; y uso del compuesto en la preparacion de un medicamento antiestrogenico, para el tratamiento de dismenorrea
ES2161288T3 (es) Comprimido revestido con polimero que comprende amoxicilina y clavulanato.
MX9405219A (es) Nueva formulacion farmaceutica.
FI973278A (fi) Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
EE200000320A (et) Uudsed ühendid
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
ES2080307T3 (es) Composiciones farmaceuticas.
CL2008003938A1 (es) Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden de estres postraumatico (divisional sol. 1799-00).
ATE210983T1 (de) Stabilisiertes kombinationsarzneimittel enthaltend naloxone und ein opiatanalgetikum
ITMO920035A1 (it) Flacone contagocce particolarmente per prodotti farmaceutici attivabili all'uso per miscelazione
ATE173923T1 (de) Oralanzuwendende flüssige arzneizubereitung enthaltend 2-(4-isobutylphenyl)propionsäure
AR011437A1 (es) Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.
ES2193233T3 (es) Uso de amiodipina, una sal de la misma o felodipina en combinacion con un inhibidor ace en la fabricacion de un medicamento para el tratamiento de insuficiencia cardiaca conjuntiva no isquemica.
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
NL193820B (nl) Vaste farmaceutische doseringsvorm voor orale toediening van Ibuprofen.
NO305286B1 (no) Kinoksalinforbindelser, farmas°ytiske preparater som omfatter dem, og anvendelse derav for fremstilling av medikamenter
FR2767526B1 (fr) Composes bi-aromatiques relies par un radical heteroethynylene et compositions pharmaceutiques et cosmetiques les contenant

Legal Events

Date Code Title Description
FB Suspension of granting procedure